Elda specializes in working with patient advocacy organizations to forge collaborations and train individuals how to be effective research advocates. Her interests include education programs that improve access to quality health care for all people, regardless of their background and socioeconomic status.
Prior to co-founding RAN, Elda was director of grants for 12 years at the Susan G. Komen Breast Cancer Foundation, where she led one of the largest programs for private funding of breast cancer research. She has reviewed for Komen, Avon-NCI Partners in Progress, and the Center for Disease Control; she is a member of the Intercultural Cancer Council, the External Advisory Board of the UCSF Breast Cancer SPORE and the Conference committee for Healthcare Advocates at the University of North Carolina, Chapel Hill, School of Public Health. Currently she as a patient advocate on:
- National Cancer Institute Early Detection Research Network (EDRN)
- National Cancer Institute Clinical Proteomics Technologies for Cancer (CPTC)
- University of Texas Southwestern Medical Center/MD Anderson Lung SPORE
In her capacity with the Coalition of National Cancer Cooperative Groups, she was a contributing author on Modules 3: Drug Development, and Module 6: Tissue and Its Use for the Patient Advocate Training Program. She has also served on the patient advocate committee for the American College of Surgeons Oncology Group.
Elda has provided consulting services to a wide range of organizations, including The Coalition of National Cancer Cooperative Groups, The National Lymphedema Network, American Society of Colon and Rectal Surgeons, and the Colorectal Cancer Network.